id: NEW:dcis_surgical_treatment_access_to_NEW:breast_cancer_specific_survival
name: Access to Surgical Treatment for DCIS â†’ Breast Cancer-Specific Survival
from_node:
  node_id: NEW:dcis_surgical_treatment_access
  node_name: Access to Surgical Treatment for DCIS
to_node:
  node_id: NEW:breast_cancer_specific_survival
  node_name: Breast Cancer-Specific Survival
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Surgical treatment removes pre-invasive ductal carcinoma tissue before malignant transformation'
- 'Step 2: Prevention of invasive progression eliminates the primary cause of breast cancer mortality
  in this population'
- 'Step 3: Lower rates of invasive ipsilateral breast tumor events translate to reduced breast cancer-specific
  deaths'
- 'Step 4: 10-year breast cancer-specific survival rates are significantly higher in surgery group (99.6%)
  compared to non-surgery (96.0%)'
evidence:
  quality_rating: A
  n_studies: 33
  primary_citation: 'Qian Chen et al. 2024. "Outcomes from low-risk ductal carcinoma in situ: a systematic
    review and meta-analysis." https://doi.org/10.1007/s10549-024-07473-w'
  supporting_citations:
  - Additional citations require full-text access - systematic review of BCSS outcomes
  - Studies reporting long-term survival outcomes after DCIS treatment
  - Ongoing trials on active surveillance mentioned as pending confirmation
  doi: 10.1007/s10549-024-07473-w
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The meta-analysis found that 10-year breast cancer-specific survival (BCSS) was significantly
  higher in patients who received surgery (99.6%) compared to those who did not (96.0%, P=0.010). This
  demonstrates that access to surgical treatment for low-risk DCIS has meaningful survival benefits.
quantitative_effects:
  p_value: 0.01
  sample_size: 47696
structural_competency:
  equity_implications: This survival benefit mechanism highlights the importance of equitable access to
    surgical oncology services. Healthcare system factors including specialist availability, hospital
    infrastructure, insurance coverage for cancer treatment, and geographic proximity to cancer centers
    determine who receives survival-improving interventions. The 3.6 percentage point absolute difference
    in 10-year survival represents a clinically meaningful disparity that could be magnified by structural
    barriers to care access.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.888446'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
